Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2996 (LINC02996)

Target
LINC02996
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding RNA
01

Overview

Long intergenic non-protein coding RNA 2996 (LINC02996) is a human long non-coding RNA (lncRNA) gene located on chromosome 5 (GRCh38: 5:42153219-42188157)[1][3][6]. It is recognized by the HGNC with approved gene symbol LINC02996 and affiliated with the lncRNA gene class[1][7]. Synonyms include IGF1R/AK000840 fusion and TCONS_00010315[6]. Its biological function is not well defined and it has not been established as a direct therapeutic target, receptor, enzyme, transporter, or other druggable protein[1][7][12]. Some database entries indicate expression or methylation in chronic lymphocytic leukemia and presence in cancer genomic studies, but there is no evidence for direct targeting with drugs or as a biomarker[12][9][11]. As a long non-coding RNA, it may potentially play a regulatory role in gene expression or chromatin modification, but experimental evidence specific to this transcript is lacking in current databases. Some sources list it in the context of fusion genes (e.g., IGF1R/AK000840 fusion), but details or functional consequences of such fusions are not described in the search results. There is no evidence for established pharmacological manipulation of this lncRNA. Despite the presence of "IGF1R" in one alias, this is not the insulin-like growth factor 1 receptor itself, nor a conventional receptor molecule. No interacting drugs, mechanisms of action, or approved biomarker status are reported in any functional or pharmacological databases[6][7][12].

Other names
IGF1R/AK000840 fusionTCONS_00010315LINC02996[1][5][6][7]
02

Mechanism of action

Not applicable

03

Biological functions

Not well characterized; putative gene regulation as a long non-coding RNA (inferred from molecular class)
04

Disease associations

Chronic lymphocytic leukemia (suggested tissue/cell specificity)Potential involvement in other cancers and complex diseases (evidence primarily from genomic context and GWAS)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2996 (LINC02996).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2996 (LINC02996).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call